Pharmaceutical Licensing Insights

News, trends, and insights for pharmaceutical manufacturers, distributors, 3PLs, and more

Kentucky Revisiting Licensing of Non-Registered Pharmacist

The Current State of Xylazine

1856 Regulatory Changes By Regulatory Agencies Since January 1st, 2024

Navigating Puerto Rico's New Licensing Standards for Pharmaceutical Wholesale Distributors

Wendie Nonclerc

Connecticut Reporting Transparency Updates

Application of AI in the Pharmaceutical Supply Chain

New Mexico Passes Prescription Drug Price Transparency Act | Effective 01/01/2025

January 31, 2024

Supreme Court Ruling on Chevron Deference Threatens to Reshape the Regulatory Landscape

January 30, 2024

Veteran’s Health Administration Announces New Trading Partner Requirements

January 25, 2024

Regulatory Recap of New State and Federal Regulation: February 2024

January 19, 2024

Third Florida Development Paints a Clear Target on Pharma Pricing

January 8, 2024

State and Federal Regulatory Changes for January 2024

December 7, 2023

2023 Letter from the CEO

October 5, 2023

Antitrust Making Headlines: A Look at Past Litigation in Pharma & Pharma Services

October 3, 2023

LighthouseAI Focuses on Superior Compliance Data

September 6, 2023

New Enforcement Tactic by the Alabama BOP for Pharmaceutical Manufacturers: Wholesaler Reporting

August 10, 2023

The Benefits of Compliance Automation in Life Sciences Supply Chain: Revolutionizing the Industry

Evolving Pharma Supply Chain Compliance: Unveiling the Power of CaaS